image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SWallowfield - Shares spike to over £4

December 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SWL
After a brief wobble the shares soared on the back of strong final results which showed revenues, pretax profit and eps rising 36%, 193% and 40% respectively to £74.3m, £5.4m and 17.7p. Excluding the transformational acquisition of Brand Architects revenues still grew 8%, helped by sterling weakness. Net debt decreased to £3.6m from £4.3m, while the dividend was raised 68% to 5.2p.To recap, its original business was contract manufacturing of personal care and cosmetics on behalf of global brand owners and retailers, such as aerosols, colour cosmetics, balms and rubs and this side produced profit of £4.8m on sales of £58m.But the real excitement is Swallowfield’s emerging owned brands division, covering areas such as skin and ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X